A pooled analysis of the prognostic value of PD-L1 in melanoma: evidence from 1062 patients

BACKGROUND: Programmed death-ligand 1 (PD-L1) was the first identified ligand of programmed death-1 (PD-1). PD-1/PD-L1 interactions inhibit T cell-mediated immune responses, limit cytokine production, and promote tumor immune escape. Recently, many studies have investigated the prognostic value of P...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jing, Dong, Meilian, Shui, Yifang, Zhang, Yue, Zhang, Zhigang, Mi, Yin, Zuo, Xiaoxiao, Jiang, Li, Liu, Ke, Liu, Zheyan, Gu, Xiaobin, Shi, Yonggang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106672/
https://www.ncbi.nlm.nih.gov/pubmed/32256205
http://dx.doi.org/10.1186/s12935-020-01187-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106672/
https://www.ncbi.nlm.nih.gov/pubmed/32256205
http://dx.doi.org/10.1186/s12935-020-01187-x

Ejemplares similares